Jeremy Bearfield
Family Medicine · Reno, NVNPI 1326337437
Payments from drug & device makers
Across 957 payments — averaging $15.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- AstraZeneca$2K
- Boehringer Ingelheim$1K
- GSK$1K
- Novo Nordisk$961
- Pfizer$952
- plus $6K from 48 others
What the payments were for
- Food & beverage$14,92199%
- Education$951%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$342
- SYMBICORT$342
- BEVESPI AEROSPHERE$192
- DALIRESP$192
- BREZTRI AEROSPHERE$150
- XARELTO$118
- Edwards SAPIEN 3 Transcatheter Heart Valve$103
How this compares
$15,015 in reported general payments places this provider in the 95th percentile of 902 family medicine providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 54 | $34,974 |
| JardianceEmpagliflozin | 27 | $32,592 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 26 | $23,935 |
| XareltoRivaroxaban | 23 | $22,726 |
| FarxigaDapagliflozin Propanediol | 12 | $11,583 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $11,229 |
| Adderall XrDextroamphetamine/Amphetamine | 11 | $4,532 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 45 | $3,514 |
| Atorvastatin Calcium | 191 | $2,769 |
| Dexlansoprazole DrDexlansoprazole | 11 | $2,686 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 83 | $2,579 |
| Tamsulosin Hcl | 89 | $2,429 |
| Pregabalin | 21 | $2,260 |
| Gabapentin | 81 | $1,900 |
| Levothyroxine Sodium | 153 | $1,886 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $952 | $34,97454 claims |
| Boehringer IngelheimJardiance | $1,039 | $32,59227 claims |
| GSKTrelegy Ellipta | $1,023 | $23,93526 claims |
| Johnson & JohnsonXarelto | $491 | $22,72623 claims |
| AstraZenecaFarxiga | $2,036 | $11,58312 claims |
| AbbVieSynthroid | $2,782 | $90712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 902 family medicine providers in Nevada.
Other family medicine in Reno
- Susan ParkReno$1.1M
- Bayo Curry-WinchellReno$74K
- Catherine McCarthyReno$68K
- Francisco DofelizReno$30K
- Michael ObrienReno$18K
- James McLennanReno$16K
- Ricardo GonzalezReno$11K
- Jennifer HornbackReno$11K
- Ambika UppuReno$11K
- Vance AlmReno$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.